Immunodominance and tumor escape

This publication has 30 references indexed in Scilit:

• A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
  The Journal of Experimental Medicine, 1997
• The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68
  The Journal of Experimental Medicine, 1997
• Immunodominant deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cellsin vitro
  Tissue Antigens, 1996
• A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
  The Journal of Experimental Medicine, 1993
• A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens.
  The Journal of Experimental Medicine, 1993
• Multiple cancers. Tumor burden permits the outgrowth of other cancers.
  The Journal of Experimental Medicine, 1985
• Evolution of tumours and the impact of molecular oncology
  Nature, 1985
• Multiple tumour-specific antigens expressed on a single tumour cell
  Nature, 1983
• Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.
  The Journal of Experimental Medicine, 1978
• Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.
  The Journal of Experimental Medicine, 1978